Condition: Type 1 Diabetes (T1D) · Sponsor: University Hospital, Grenoble
Prospective, multicenter, descriptive cohort (RIPH3 study under the Jardé Act), STABILOOP study aims to describe whether BF may be an appropriate therapeutic option for the cohort of patients who are theoretically candidates for Islet transplantation, by describing Closed-Loop failures at 12 months in patients referred to an expert center for management of unstable diabetes.
This description comes directly from the study's public registry record.
Myriam HADDOUCHE · +33476765509 · mhaddouche@chu-grenoble.fr
Always discuss trial participation with your own doctor first.
| HCL - Edouard Herriot Hospital | Lyon, Auvergne-Rhône-Alpes, France | Recruiting |
| Hospices Civils de Lyon - Lyon Sud | Pierre-Bénite, Auvergne-Rhône-Alpes, France | Recruiting |
| Strasbourg Civil Hospital | Strasbourg, Grand Est, France | Recruiting |
| Grenoble University Hospital | La Tronche, ISERE, France | Recruiting |
| Montpellier University Hospital - Lapeyronnie Hospital | Montpellier, Occitanie, France | Recruiting |
| Toulouse University Hospital - Hôpital Rangueil | Toulouse, Occitanie, France | Recruiting |
| APH Paris - LARIBOISIERE Hospital | Paris, Île-de-France Region, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07006272